blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2712618

EP2712618 - Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  25.08.2017
Database last updated on 03.10.2024
Most recent event   Tooltip25.08.2017No opposition filed within time limitpublished on 27.09.2017  [2017/39]
Applicant(s)For all designated states
EnGeneIC Molecular Delivery Pty Ltd.
Building 2, 25 Sirius Road
Lane Cove West
NSW 2066 / AU
[2017/03]
Former [2014/14]For all designated states
EnGeneIC Molecular Delivery Pty Ltd.
105 Delhi Road, Riverside Corporate Park North Ryde
Sydney NSW 2113 / AU
Inventor(s)01 / BRAHMBHATT, Himanshu
96 Prairie Vale Road
Bossley Park
Sydney, New South Wales 2176 / AU
02 / MACDIARMID, Jennifer
8 Lombard Street Glebe
Sydney, New South Wales 2037 / AU
 [2016/42]
Former [2014/14]01 / Brahmbhatt, Himanshu
96 Prairie Vale Road
Bossley Park
Sydney, New South Wales 2176 / AU
02 / Macdiarmid, Jennifer
8 Lombard Street Glebe
Sydney, New South Wales 2037 / AU
Representative(s)Plougmann Vingtoft a/s
Strandvejen 70
2900 Hellerup / DK
[N/P]
Former [2016/42]Plougmann Vingtoft a/s
Rued Langgaards Vej 8
2300 Copenhagen S / DK
Former [2014/14]Plougmann & Vingtoft A/S
Rued Langgaards Vej 8
2300 Copenhagen S / DK
Application number, filing date13191266.920.06.2007
[2014/14]
Priority number, dateUS20060815883P23.06.2006         Original published format: US 815883 P
US20070909078P30.03.2007         Original published format: US 909078 P
[2014/14]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2712618
Date:02.04.2014
Language:EN
[2014/14]
Type: B1 Patent specification 
No.:EP2712618
Date:19.10.2016
Language:EN
[2016/42]
Search report(s)(Supplementary) European search report - dispatched on:EP05.03.2014
ClassificationIPC:A61K47/48, C07K16/12, C07K16/28
[2016/10]
CPC:
A61K31/337 (EP,US); A61K47/46 (US); A61K31/704 (EP,US);
A61K31/7088 (EP,US); A61K31/7105 (EP,US); A61K31/711 (EP,US);
A61K31/713 (EP,US); A61K47/6849 (EP,US); A61K47/6901 (EP,US);
A61K48/0008 (EP,US); A61P35/00 (EP); A61P43/00 (EP);
C07K16/1203 (EP,US); C07K16/1235 (EP,US); C07K16/2863 (EP,US);
A61K2039/505 (EP,US); A61K48/00 (EP,US); C07K2317/31 (EP,US);
Y02A50/30 (US) (-)
Former IPC [2014/14]A61K35/74, A61K31/7105, A61K31/713, A61K31/7088, A61K31/711, A61P35/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2016/42]
Former [2014/14]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:Gezielte Verabreichung von Wirkstoffen, therapeutischen Nukleinsäuren und funktionellen Nukleinsäuren in Säugetierzellen mithilfe intakter getöteter Bakterienzellen[2014/14]
English:Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells[2014/14]
French:Administration ciblée de médicaments, d'acides nucléiques thérapeutiques et d'acides nucléiques fonctionnels à des cellules mammaliennes via des cellules bactériennes tuées[2014/14]
Examination procedure01.10.2014Amendment by applicant (claims and/or description)
01.10.2014Examination requested  [2014/46]
27.11.2014Despatch of a communication from the examining division (Time limit: M06)
04.06.2015Reply to a communication from the examining division
29.06.2015Despatch of a communication from the examining division (Time limit: M04)
04.11.2015Reply to a communication from the examining division
03.05.2016Communication of intention to grant the patent
09.09.2016Fee for grant paid
09.09.2016Fee for publishing/printing paid
09.09.2016Receipt of the translation of the claim(s)
16.03.2017Request for correction of the decision to grant filed
Parent application(s)   TooltipEP07825666.6  / EP2040725
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20070825666) is  14.06.2012
Opposition(s)20.07.2017No opposition filed within time limit [2017/39]
Fees paidRenewal fee
01.11.2013Renewal fee patent year 03
01.11.2013Renewal fee patent year 04
01.11.2013Renewal fee patent year 05
01.11.2013Renewal fee patent year 06
01.11.2013Renewal fee patent year 07
31.03.2014Renewal fee patent year 08
19.06.2015Renewal fee patent year 09
27.06.2016Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]WO9507346  (AMERSHAM INT PLC [GB], et al);
 [Y]DE19909770  (LUBITZ WERNER [AT]);
 [Y]US6177083  (LUBITZ WERNER [AT]);
 [Y]WO0232395  (ADVANCED DELIVERY SYSTEMS APS [DK], et al);
 [Y]US2005222057  (BRAHMBHATT HIMANSHU [AU], et al);
 [Y]US2006018877  (MIKSZTA JOHN A [US], et al);
by applicantWO8101145
 US4496778
 WO8807378
 US4975278
 US4987071
 US5037743
 US5143830
 US5260203
 WO9521191
 US5455030
 US5530101
 US5585089
 US6025197
 WO0067776
 US2003004123
 US6639055
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.